ELIZABETH A. GAROFALO - 05 Mar 2025 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
05 Mar 2025
Net transactions value
-$89,673
Form type
4
Filing time
06 Mar 2025, 18:30:15 UTC
Previous filing
12 Jun 2024
Next filing
02 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Sale $89,673 -4,919 -22% $18.23 17,595 05 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.